Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
accessed, acne, acquisition, Adjunct, agonist, Amgen, Amsterdam, approach, asS, attest, attestation, attract, attractive, auditor, Baltimore, Belgian, Belgium, belief, Caliper, capacity, care, Centre, chronic, clindamycin, confer, confidence, Conforma, contractility, copy, COSO, Counsel, count, CRADA, CTEP, cumulative, damage, de, decade, decision, deprive, desire, detail, detaining, disposition, DMAG, DuPont, duration, ear, Edward, EMEA, encode, enterprise, Ericsson, eye, Formal, frequency, front, Gastroenterology, GBF, German, glycosylation, Greenbaum, healthcare, hearing, hematologic, hire, illustration, impede, ineffective, infection, introduction, ISSUER, iv, Japanese, joint, Jon, Leiden, lengthy, leukemia, Leuven, liable, MacMillan, Madison, Maryland, motilin, motivate, mutual, myeloma, NW, NYSE, opposition, Oregon, orphan, Oversight, owner, oxaliplatin, persuasive, pertain, Pieter, point, political, Pont, predetermined, preliminary, prohibiting, prolonged, proper, prostate, raw, Raychem, recall, regional, resprectively, revised, Room, salary, Sausville, Schering, seizing, shareholder, shift, Simon, skin, solid, Specimen, speed, spent, stipulated, Street, supervision, supplier, suspension, Telefonaktiebolaget, tetracycline, Theo, therapy, thereon, Thorson, threaten, timeframe, Today, topical, traditional, transport, Treadway, Treaty, Tularik, unanticipated, unilaterally, unqualified, updated, upfront, Velcade, violation, visible, warning, Washington, Wisconsin, Xcyte
Removed:
achieving, Additionally, appointed, attain, attrition, auditing, beneficiary, Biaxin, CIBC, combined, compensate, conform, Cowen, critically, Crucell, diminish, disable, discodermolide, discovering, easy, enforceability, Fidelity, functional, ill, Ketek, lapsing, Lehman, locate, misuse, misused, Neurobiological, Pfizer, potent, put, residential, respiratory, seeking, SG, show, side, trust, unexpired, unit, validity, world, Zithromax
Filing tables
Filing exhibits
- 10-K Annual report
- 10.32 Executive Compensation Arrangements
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification of Chief Executive Officer Pursuant to Section 302
- 31.2 Certification of Chief Financial Officer Pursuant to Section 302
- 32.1 Certifications of Chief Executive and Financial Officers Pursuant to Section 906
Related press release
KOSN similar filings
Filing view
External links
EXHIBIT 10.32
SALARY INFORMATION FOR EXECUTIVE OFFICERS
The table below provides information regarding the salary of each executive officer of Kosan Biosciences Incorporated (“Kosan”) as of March 15, 2005. All other compensation arrangements between Kosan and each of its executive officers are referenced in the Exhibit Index to this Annual Report on Form 10-K.
Executive Officer | Salary | ||
Daniel V. Santi, M.D., Ph.D. | $ | 425,000 | |
Robert G. Johnson, Jr., M.D., Ph.D. | $ | 350,000 | |
Susan M. Kanaya | $ | 292,000 | |
Bruce E. MacMillan | $ | 252,000 |